CSF neurofilament light may predict progression from amnestic mild cognitive impairment to Alzheimer's disease dementia
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CSF neurofilament light may predict progression from amnestic mild cognitive impairment to Alzheimer's disease dementia
Authors
Keywords
Alzheimer's disease, Biomarker, Neurofilament Light, Cerebrospinal fluid, Predict Progression
Journal
NEUROBIOLOGY OF AGING
Volume 107, Issue -, Pages 78-85
Publisher
Elsevier BV
Online
2021-07-25
DOI
10.1016/j.neurobiolaging.2021.07.013
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Amyloid, Tau, and Neurodegeneration (A/T/N) Classification Applied to a Clinical Research Cohort with Long-Term Follow-Up
- (2020) Gøril Rolfseng Grøntvedt et al. JOURNAL OF ALZHEIMERS DISEASE
- Differential levels of Neurofilament Light protein in cerebrospinal fluid in patients with a wide range of neurodegenerative disorders
- (2020) C. Delaby et al. Scientific Reports
- Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study
- (2019) Alberto Lleó et al. Alzheimers & Dementia
- Neurofilament light chain as a biomarker in neurological disorders
- (2019) Lorenzo Gaetani et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Neurofilament Light Chain as a Biomarker in Multiple Sclerosis
- (2019) Kristin N. Varhaug et al. Frontiers in Neurology
- Plasma and CSF neurofilament light
- (2019) Michelle M. Mielke et al. NEUROLOGY
- Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
- (2019) Sebastian Palmqvist et al. EMBO Molecular Medicine
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Plasma Amyloid-β (Aβ42) Correlates with Cerebrospinal Fluid Aβ42 in Alzheimer’s Disease
- (2018) Charlotte E. Teunissen et al. JOURNAL OF ALZHEIMERS DISEASE
- Biomarkers for Alzheimer's disease: current status and prospects for the future
- (2018) K. Blennow et al. JOURNAL OF INTERNAL MEDICINE
- Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
- (2018) Piotr Lewczuk et al. Alzheimers Research & Therapy
- Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease
- (2018) Yung-Shuan Lin et al. Scientific Reports
- Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
- (2017) Piotr Lewczuk et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease
- (2017) Niklas Mattsson et al. JAMA Neurology
- Alpha-synuclein measured in cerebrospinal fluid from patients with Alzheimer’s disease, mild cognitive impairment, or healthy controls: a two year follow-up study
- (2016) Guro Berge et al. BMC Neurology
- A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
- (2016) Clifford R. Jack et al. NEUROLOGY
- Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression
- (2016) Henrik Zetterberg et al. JAMA Neurology
- Biomarker progressions explain higher variability in stage-specific cognitive decline than baseline values in Alzheimer disease
- (2014) Hiroko H. Dodge et al. Alzheimers & Dementia
- Apolipoprotein E 2 genotype delays onset of dementia with Lewy bodies in a Norwegian cohort
- (2014) G. Berge et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
- (2013) Clifford R Jack et al. LANCET NEUROLOGY
- Neurofilaments at a glance
- (2012) A. Yuan et al. JOURNAL OF CELL SCIENCE
- Serial CSF sampling in Alzheimer's disease: specific versus non-specific markers
- (2011) Maartje I. Kester et al. NEUROBIOLOGY OF AGING
- Rate of progression of mild cognitive impairment to dementia - meta-analysis of 41 robust inception cohort studies
- (2009) A. J. Mitchell et al. ACTA PSYCHIATRICA SCANDINAVICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search